Hints and tips:
Showing results for JACOBUS PHARMACEUTICAL COMPANY, INC.
Related Special Reports
...“We have made tremendous progress in strengthening the financial position of the company,” it added....
...The windfall from Covid vaccines gives the company the money to back research for many jabs. But investors have also been nervous about how much the company has been spending....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...Any rumours that the company is at risk of defaulting are “flatly untrue”, he said....
...Shockwave’s technology has treated approximately 400,000 patients globally, the company said....
...Illumina said the company agreed “with the advocate general that the European Commission’s assertion of jurisdiction over this merger was improper”. Illumina bought Grail in 2021....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...Pfizer shares tumbled more than 8 per cent after the US drugmaker forecast 2024 revenues that were below consensus estimates, as the company attempts to chart a future for growth without blockbuster Covid...
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...Packaged food companies have built strong and trusted brands over decades....
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
...Large pharmaceutical companies are increasingly interested in immunology — tackling diseases often caused by an overactive immune system — because of the large number of affected patients....
...The prolonged legal battle and mounting competition in the genomics industry have caused investors to question the company’s strategy to diversify into cancer diagnostics....
...The move is a rare one for regulators to take and is designed to dissuade other companies from defying their authority....
...Albert Bourla, Pfizer’s chief executive, said the company’s product portfolio, apart from Covid medicines, remained strong, with the company expecting revenues from the rest of the business to grow between...
...The world’s top global tech and pharmaceutical companies have set up in the country and are major contributors to state coffers via their taxes....
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...One example comes from a comparison of the disclosures by WuXi Biologics, a pharmaceutical company that listed in 2017, and WuXi XDC, a unit it spun off and listed last year....
...The California-based pharmaceutical company agreed to the acquisition in December last year, winning a three-way race to add a new pipeline of drugs for rare autoimmune and inflammatory diseases....
International Edition